UN Photo/Christopher Black Events | 01 February 2023 MSF statements at WHO Executive Board 152nd session 1 min UN Photo/Christopher Black UN Photo/Christopher Black MSF representatives will speak at the 152nd session of the WHO Executive Board (EB) on a number of topics. Statement | 01 February 2023 Research and development MSF Statement on EB152/13 - Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination 1 min Statement | 01 February 2023 Research and development MSF Statement on EB152/7 - Substandard and falsified medical products 1 min Statement | 01 February 2023 Diagnostics MSF Statement on EB152/5 - Strengthening diagnostics capacity 1 min Don't miss out! Sign up to stay updated and find out how you can get involved. Email Address Data protection consent Read, watch, share Filter by - Any -EventsIssue briefLetterPress releaseSpeechStatement Statement | 03 February 2020 Research and development WHO 146th EB - 2.1 - WHO reform Involvement of non-State actors in WHO’s governing bodies 2 min Issue brief Issue brief | 28 January 2020 Diabetes A century of neglect: challenges of access to insulin for diabetes care Statement | 31 January 2019 Antimicrobial resistance 144th WHO EB: Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues: Antimicrobial resistance 2 min Statement | 30 January 2019 Tuberculosis 144th WHO EB: Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues: Ending tuberculosis 2 min Statement | 29 January 2019 Research and development 144th WHO EB: Medicines, vaccines and health products - Access to medicines and vaccines 2 min UN Photo/Christopher Black Events Events | 29 January 2019 MSF statements at WHO Executive Board 144th session Statement | 29 January 2019 Research and development 144th WHO EB: Medicines, vaccines and health products: Cancer medicines 2 min Statement | 24 January 2018 Vaccines 142nd WHO EB Agenda item 6.2 Global vaccine action plan Load More
Statement | 01 February 2023 Research and development MSF Statement on EB152/13 - Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination 1 min
Statement | 01 February 2023 Research and development MSF Statement on EB152/7 - Substandard and falsified medical products 1 min
Statement | 01 February 2023 Diagnostics MSF Statement on EB152/5 - Strengthening diagnostics capacity 1 min
Statement | 03 February 2020 Research and development WHO 146th EB - 2.1 - WHO reform Involvement of non-State actors in WHO’s governing bodies 2 min
Issue brief Issue brief | 28 January 2020 Diabetes A century of neglect: challenges of access to insulin for diabetes care
Statement | 31 January 2019 Antimicrobial resistance 144th WHO EB: Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues: Antimicrobial resistance 2 min
Statement | 30 January 2019 Tuberculosis 144th WHO EB: Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues: Ending tuberculosis 2 min
Statement | 29 January 2019 Research and development 144th WHO EB: Medicines, vaccines and health products - Access to medicines and vaccines 2 min
UN Photo/Christopher Black Events Events | 29 January 2019 MSF statements at WHO Executive Board 144th session
Statement | 29 January 2019 Research and development 144th WHO EB: Medicines, vaccines and health products: Cancer medicines 2 min
